SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ALS Therapy Development Institute Announces Research Agreement with Biogen Idec, Inc. (Massachusetts) and UCB Pharma to Investigate the Role of CD40L in ALS